Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.4 USD | -0.94% | -17.04% | -24.95% |
Apr. 18 | Recursion Pharmaceuticals Insider Sold Shares Worth $367,007, According to a Recent SEC Filing | MT |
Apr. 16 | Recursion Pharmaceuticals Names Najat Khan Chief R&D Officer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.95% | 1.74B | |
-3.30% | 102B | |
+1.79% | 96.07B | |
-1.19% | 21.66B | |
-18.35% | 20.77B | |
-8.33% | 18.53B | |
-40.31% | 16.91B | |
-26.84% | 13.79B | |
+0.59% | 13.33B | |
+20.86% | 10.94B |
- Stock Market
- Equities
- RXRX Stock
- News Recursion Pharmaceuticals, Inc.
- Berenberg Bank Adjusts Recursion Pharmaceuticals' Price Target to $38 From $36, Maintains Buy Rating